Format

Send to

Choose Destination
See comment in PubMed Commons below
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10 Pt 2):78-81.

[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].

[Article in Russian]

Abstract

Teriflunomide is a once-daily, orally administered, disease-modifying drug. The review presents the data concerning the mechanism of action, pharmacokinetics as well as results of clinical studies. Teriflunomide has received the regulatory approval in the USA, Argentina, Australia, South Korea, Chile and EU. The submission of a regulatory dossier is performed in Russia.

PMID:
24416812
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk